share_log

Greenlight Biosciences And Epivax Therapeutics Signed Exclusive Collaboration Agreement To Develop Personalized Cancer Vaccines

Greenlight Biosciences And Epivax Therapeutics Signed Exclusive Collaboration Agreement To Develop Personalized Cancer Vaccines

Greenlight Biosciences和Epivax Therapeutics签署了开发个性化癌症疫苗
Benzinga Real-time News ·  2023/01/09 07:22

GreenLight Biosciences Holdings, PBC (NASDAQ:GRNA), and EpiVax Therapeutics Inc, today announced that they have signed an exclusive collaboration agreement to jointly develop and commercialize personalized mRNA-based vaccine candidates for cancers.

GreenLight Biosciences Holdings、PBC(纳斯达克股票代码:GRNA)和EpiVax Therapeutics Inc今天宣布,他们已经签署了一项独家合作协议,共同开发和商业化基于mRNA的个性化癌症候选疫苗。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发